Last reviewed · How we verify
Elobixibat 10mg
At a glance
| Generic name | Elobixibat 10mg |
|---|---|
| Also known as | AJG533 10 mg |
| Sponsor | Yokohama City University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Elobixibat for Chronic Constipation Without Defecation Desire (PHASE4)
- Long-term Elobixibat for Chronic Constipation (PHASE4)
- Elobixibat for Chronic Constipation Without Defecation Desire (PHASE4)
- Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |